Abstract
Translational medicine is characterized by its close association with precision medicine in the field of colo-rectal cancer. In particular, the studies of life histology promote the prevention and treatment of colorectal cancer entered the stage of precision medicine. Accurate molecular typing of colo-rectal cancer has been used to guide clinical practice is an important breakthrough in the field of colorectal cancer translational medicine in recent years, and its clinical value has been verified. As an important tool for the effective integration of clinical data and life histology data, the biomedical big data platform is expected to contribute to the continued breakthrough of translational medicine in precision molecular typing. New treatment methods, such as liquid biopsy technology with non-invasive, flexible features can be dynamically detected as soon as possible to find the state of somatic mutations. Among them, circulating tumor DNA has a good detection sensitivity and specificity, highlighting the value of early recurrence monitoring. In addition, new therapeutic strategies, such as immunological checkpoints and chimeric antigen receptor genetically modified T-cell therapy, are under intense study in the field of colorectal cancer. Based on the biomedical big data analysis in the context of the precise molecular typing, dynamic liquid biopsy monitoring technology, new immunotherapy and other fields will be the future of colorectal cancer translational medicine research hot and breakthrough direction. Key words: Colorectal neoplasms; Translational medicine; Precision medicine; Mole-cular subtyping; Big data; Liquid biopsy technology; Immunologic therapy
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
